The Senate Judiciary Committee today passed four bills aimed at lowering prescription drug costs and increasing competition.

  • The Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S. 1224) would make it illegal for drug makers to use “sham” citizen petitions to delay or keep low-cost generic competitors off the market.
  •  The Prescription Pricing for the People Act (S. 1227) would require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations.
  •  The Preserving Access to Cost Effective Drugs Act (S. 440) would prohibit patent owners from asserting sovereign immunity as a defense in certain actions before the U.S. Patent and Trademark Office to prevent production of generic medications.
  •  The Affordable Prescriptions for Patients Act (S. 1416) would amend the FTC Act to prohibit anticompetitive behaviors by drug product manufacturers, among other provisions. 

These bills could be combined with drug pricing proposals from the Senate Health, Education, Labor and Pensions Committee and Senate Finance Committee. 

Related News Articles

Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…
Headline
The Department of Health and Human Services today announced prescription drug reforms that will become effective Oct. 1 originating from the Health Data,…
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…
Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Chairperson's File
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue…